市場調查報告書
商品編碼
1408987
全球極外側椎間融合 (XLIF) 手術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球極外側椎間融合術 (XLIF) 手術市場的需求預計將從 2022 年的 10 億美元增至 2030 年的近 15.9 億美元,2023 年至 2030 年的研究期間CAGR為 5.89%。
極外側椎間融合術 (XLIF) 是一種透過從側面進入脊椎(外側入路)來治療某些脊椎疾病的外科手術。這種微創技術使外科醫生能夠解決退化性椎間盤疾病、椎間盤突出或脊椎不穩定等問題,而無需採用傳統的後路或前路方法。
對微創脊椎手術的需求和脊椎手術技術的進步推動了極外側椎間融合手術市場的發展。該手術是傳統脊椎手術的一種侵入性較小的替代方案,因其潛在的好處而受到患者的青睞,包括縮短恢復時間和減少術後疼痛。全球人口老化導致脊椎退化性疾病的發生率不斷增加,推動了對 XLIF 手術的需求。手術技術和影像技術的不斷進步以及外科醫生的採用,提高了手術的精確度和安全性。患者對微創手術的偏好與 XLIF 手術一致,進一步提高了其受歡迎程度。有利的報銷政策、積極的臨床結果以及支持 XLIF 療效的證據有助於其在醫學界的接受。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球極端側向椎間融合 (xlif) 手術市場的各個細分市場進行了包容性評估。極端側向椎間融合 (xlif) 手術產業的成長和趨勢為這項研究提供了整體方法。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的極外側椎間融合 (XLIF) 手術市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。極外側椎間融合(XLIF) 手術市場的主要參與者包括美敦力公司(Medtronic plc)、強生公司(Johnson & Johnson)、史賽克公司(Stryker Corporation)、Zimmer Biomet Holdings Inc.、NuVasive Inc.、Globus Medical Inc.、DePuy Synthes、B. Braun Melsungen AG、Alphatec Holdings Inc.、RTI Surgical Holdings Inc.、K2M Group Holdings Inc.、Orthofix Medical Inc.、Aesculap Implant Systems、SpineWave Inc.、MicroPort Scientific Corporation、Life Spine Inc .、Captiva Spine Inc.。競爭格局,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Extreme Lateral Interbody Fusion (XLIF) Surgery Market is presumed to reach the market size of nearly USD 1.59 BN by 2030 from USD 1 BN in 2022 with a CAGR of 5.89% under the study period 2023 - 2030.
Extreme Lateral Interbody Fusion (XLIF) is a surgical procedure used to treat certain spinal conditions by accessing the spine from the side (lateral approach). This minimally invasive technique allows surgeons to address issues such as degenerative disc disease, disc herniation, or instability of the spine without the need for traditional posterior or anterior approaches.
The extreme lateral interbody fusion surgery market is fueled by the demand for minimally invasive spinal procedures and advancements in spinal surgery techniques. Offering a less invasive alternative to traditional spinal surgeries, this procedure is preferred by patients for its potential benefits, including shorter recovery times and reduced postoperative pain. The aging global population contributes to the increasing incidence of degenerative spinal conditions, driving the demand for XLIF procedures. Ongoing technological advancements in surgical technologies and imaging, along with its adoption by surgeons, enhance the precision and safety of the procedure. Patient preferences for minimally invasive options align with XLIF surgery, further boosting its popularity. Favorable reimbursement policies, positive clinical outcomes, and evidence supporting XLIF's efficacy contribute to its acceptance within the medical community.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extreme lateral interbody fusion (xlif) surgery. The growth and trends of extreme lateral interbody fusion (xlif) surgery industry provide a holistic approach to this study.
This section of the extreme lateral interbody fusion (xlif) surgery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Extreme Lateral Interbody Fusion (XLIF) Surgery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extreme Lateral Interbody Fusion (XLIF) Surgery market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG, Alphatec Holdings Inc., RTI Surgical Holdings Inc., K2M Group Holdings Inc., Orthofix Medical Inc., Aesculap Implant Systems, SpineWave Inc., MicroPort Scientific Corporation, Life Spine Inc., Captiva Spine Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.